Peptide and Oligonucleotide CDMO Market Expands with Rising Biopharma Outsourcing
The increasing complexity of modern therapeutics has significantly accelerated demand for peptide contract manufacturing market solutions, oligonucleotide manufacturing services, and broader CDMO pharmaceutical outsourcing models. As pharmaceutical companies focus more on innovation and less on in-house production, Contract Development and Manufacturing Organizations...
0 Comentários 0 Compartilhamentos 5 Visualizações